A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.
DOI identifier: 10.1038/ng1542
Sorry, we are unable to provide the full text but you may find it at the following location(s):
http://hdl.handle.net/2381/203... (external link)
http://dx.doi.org/10.1038/ng15... (external link)